Skip to main content

Carcinoma della prostata: aspetti istopatologici e inquadramento clinico

  • Chapter
  • 601 Accesses

Riassunto

Nonostante i recenti miglioramenti nella diagnosi e nel trattamento, il cancro della prostata continua a essere la più comune neoplasia maligna e la terza causa di morte per cancro nella popolazione statunitense.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592

    Article  PubMed  CAS  Google Scholar 

  2. Soh S, Kattan MW, Berkman S et al (1997) Has there been a recent shift in the pathological features and prognosis of patients with radical prostatectomy? J Urol 157:2212–2218

    Article  PubMed  CAS  Google Scholar 

  3. Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA Cancer J Clin 40:9–26

    Article  PubMed  CAS  Google Scholar 

  4. Potoscky AL, Feuer EJ, Levin DL (2001) Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 23(1):181–186

    Google Scholar 

  5. Smith RA, von Eschenbach AC, Wender R et al (2001) American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 51(1):38–75

    Article  PubMed  CAS  Google Scholar 

  6. American Medical Association (2001) Report 9 of the Council on Scientific Affairs (A-00). Screening and Early Detection of Prostate Cancer. June

    Google Scholar 

  7. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142(1):71–74

    PubMed  CAS  Google Scholar 

  8. Eskew LA, Bare RL, McCullough DL (1997) Systemic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157(1):199–202

    Article  PubMed  CAS  Google Scholar 

  9. Fukagai T, Namiki T, Carlile RG et al (2001) Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathol Int 51:364–372

    Article  PubMed  CAS  Google Scholar 

  10. D’Amico AV, Renshaw AA, Arsenault L et al (1999) Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patients selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys 45:841–895

    PubMed  Google Scholar 

  11. Kulkarni GS, Al-Azab R, Lockwood G et al (2006) Evidence for a biopsy derived grade artefact among larger prostate glands. J Urol 175:505–509

    Article  PubMed  Google Scholar 

  12. Redman MW, Tangen CM, Goodman PJ et al (2008) Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res (Phila Pa) 1(3):182–186

    Google Scholar 

  13. Sciarra A, Autran Gomez A, Salciccia S et al (2008) Biopsy-derived Gleason artifact and prostate volume: experience using ten samples in larger prostates. Urol Int 80(2):145–50

    Article  PubMed  Google Scholar 

  14. Divrik RT, Eroglu A, Sahin A et al (2007) Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol Oncol 25(5):376–382

    PubMed  Google Scholar 

  15. Stamey TA (1995) Second Stanford Conference on international standardization of prostate-specific antigen immunoassays: Urology 45:173–184

    Article  PubMed  CAS  Google Scholar 

  16. European Association of Urology (2009) Guidelines on prostate cancer (http://www.uroweb.org/nc/professional-resources/guidelines/online/)

    Google Scholar 

  17. Babaian RJ, Sayer J, Podoloff D (1994) Radioimmunoscintigraphy of pelvic lymphonodes with 111indium-labeled monoclonal antibody CYT-365. J Urol 152(6 Pt 1):1952–1955.

    PubMed  CAS  Google Scholar 

  18. Salminen E, Hogg A, Binns D et al (2002) Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta Oncol 41(5):425–429

    Article  PubMed  Google Scholar 

  19. Ohori M, Kattan MW, Koh H et al (2004) Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 171(5):1844–1849

    Article  PubMed  Google Scholar 

  20. Amling CL, Bergstralh EJ, Blute ML et al (2001) Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165:1146–1151

    Article  PubMed  CAS  Google Scholar 

  21. Pound CR, Partin AW, Eisenberger MA et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591–1597

    Article  PubMed  CAS  Google Scholar 

  22. Neulander EZ, Soloway MS (2003) Failure after radical prostatectomy. Urology 61:30–36

    Article  PubMed  Google Scholar 

  23. Rabbani F, Stapleton AM, Kattan MW et al (2002) Factors predicting recovery of erections after radical prostatectomy. J Urol 164:1929–193

    Article  Google Scholar 

  24. Takenaka A, Murakami G, Mastubara A et al (2005) Variation in course of cavernous nerve with special reference to details of topographic relationships near prostatic apex: histologic study using male cadavers. Urology 65(1):136–42

    Article  PubMed  Google Scholar 

  25. Kawanishi Y, Lee KS, Kimura K et al (2001) Effect of radical retropubic prostatectomy on erectile function, evaluated before and after surgery using colour Doppler ultrasonography and nocturnal penile tumescence monitoring. BJU Int 88(3):244–247

    Article  PubMed  CAS  Google Scholar 

  26. Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of abridged, 5-items version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326

    Article  PubMed  CAS  Google Scholar 

  27. Sciarra A, Panebianco V, Salciccia S et al (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54(3):589–600

    Article  PubMed  Google Scholar 

  28. Panebianco V, Sciarra A, Osimani M et al (2009) 2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation. Eur Radiol 19(1):220–229

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Italia

About this chapter

Cite this chapter

Salciccia, S., Sciarra, A. (2010). Carcinoma della prostata: aspetti istopatologici e inquadramento clinico. In: Passariello, R., Panebianco, V., Di Silverio, F., Sciarra, A. (eds) Imaging RM della prostata. Springer, Milano. https://doi.org/10.1007/978-88-470-1516-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1516-6_12

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1515-9

  • Online ISBN: 978-88-470-1516-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics